Immunoglobulin superfamily members encoded by viruses and their multiple roles in immune evasion

European Journal of Immunology

Volumn 47, Issue 5, 2017, Pages 780-796

  Farré, Domènec ^a   Martínez Vicente, Pablo ^a   Engel, Pablo ^a,b   Angulo, Ana ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Horizontal gene transfer; Immune evasion; Immunoglobulin superfamily; Large DNA viruses; Viral evolution

Indexed keywords

B7 ANTIGEN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CD200 ANTIGEN; CD47 ANTIGEN; FC RECEPTOR; IMMUNOGLOBULIN; INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 18 BINDING PROTEIN; SIGNALING LYMPHOCYTIC ACTIVATION MOLECULE; ANTIGENS, CD200; DNA VIRUS; INTERLEUKIN-18 BINDING PROTEIN; LEUKOCYTE ANTIGEN; SIGNAL PEPTIDE; VIRAL PROTEIN;

ADENOVIRIDAE; EVOLUTION; GENE FUNCTION; HERPESVIRIDAE; HORIZONTAL GENE TRANSFER; IMMUNE EVASION; IMMUNOMODULATION; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; NONHUMAN; POXVIRIDAE; PRIORITY JOURNAL; REVIEW; VIRUS; VIRUS GENOME; ANIMAL; GENETICS; HUMAN; HUMAN ADENOVIRUS C; IMMUNOGLOBULIN GENE; IMMUNOLOGY; METABOLISM; MOLECULAR EVOLUTION; PATHOGENICITY;

ADENOVIRUSES, HUMAN; ANIMALS; ANTIGENS, CD; DNA VIRUSES; EVOLUTION, MOLECULAR; GENE TRANSFER, HORIZONTAL; GENES, IMMUNOGLOBULIN; HERPESVIRIDAE; HUMANS; IMMUNE EVASION; IMMUNOGLOBULINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; VIRAL PROTEINS;

EID: 85019043622     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201746984     Document Type: Review

References (114)

1. Holzerlandt, R., Orengo, C., Kellam, P. and Albà, M. M., Identification of new herpesvirus gene homologs in the human genome. Genome Res. 2002. 12: 1739–1748.
2. Hughes, A. L., Irausquin, S. and Friedman, R., The evolutionary biology of poxviruses. Infect. Genet. Evol. 2010. 10: 50–59.
3. Engel, P. and Angulo, A., Viral immunomodulatory proteins: usurping host genes as a survival strategy. Adv. Exp. Med. Biol. 2012. 738: 256–276.
4. Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K. et al., Initial sequencing and analysis of the human genome. Nature 2001. 409: 860–921.
5. Barclay, A. N., Membrane proteins with immunoglobulin-like domains—a master superfamily of interaction molecules. Semin. Immunol. 2003. 15: 215–223.
6. Garlanda, C., Dinarello, C. A. and Mantovani, A., The interleukin-1 family: back to the future. Immunity 2013. 39: 1003–1018.
7. Boratyn, G. M., Schäffer, A. A., Agarwala, R., Altschul, S. F., Lipman, D. J. and Madden, T. L., Domain enhanced lookup time accelerated BLAST. Biol. Direct 2012. 7: 12.
8. Barclay, A. N., Wright, G. J., Brooke, G. and Brown, M. H., CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol. 2002. 23: 285–290.
9. Hatherley, D., Lea, S. M., Johnson, S. and Barclay, A. N., Structures of CD200/CD200 receptor family and implications for topology, regulation, and evolution. Structure 2013. 21: 820–832.
10. Preston, S., Wright, G. J., Starr, K., Barclay, A. N. and Brown, M. H., The leukocyte/neuron cell surface antigen OX2 binds to a ligand on macrophages. Eur. J. Immunol. 1997. 27: 1911–1918.
11. Shiratori, I., Yamaguchi, M., Suzukawa, M., Yamamoto, K., Lanier, L. L., Saito, T. and Arase, H., Down-regulation of basophil function by human CD200 and human herpesvirus-8 CD200. J. Immunol. 2005. 175: 4441–4449.
12. Rijkers, E. S., de Ruiter, T., Baridi, A., Veninga, H., Hoek, R. M. and Meyaard, L., The inhibitory CD200R is differentially expressed on human and mouse T and B lymphocytes. Mol. Immunol. 2008. 45: 1126–1135.
13. Hoek, R. M., Ruuls, S. R., Murphy, C. A., Wright, G. J., Goddard, R., Zurawski, S. M., Blom, B. et al., Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 2000. 290: 1768–1771.
14. Wright, G. J., Puklavec, M. J., Willis, A. C., Hoek, R. M., Sedgwick, J. D., Brown, M. H. and Barclay, A. N., Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 2000. 13: 233–242.
15. Snelgrove, R. J., Goulding, J., Didierlaurent, A. M., Lyonga, D., Vekaria, S., Edwards, L., Gwyer, E. et al., A critical function for CD200 in lung immune homeostasis and the severity of influenza infection. Nat. Immunol. 2008. 9: 1074–1083.
16. Coles, S. J., Wang, E. C., Man, S., Hills, R. K., Burnett, A. K., Tonks, A. and Darley, R. L., CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia. Leukemia 2011. 25: 792–799.
17. Coles, S. J., Hills, R. K., Wang, E. C., Burnett, A. K., Man, S., Darley, R. L. and Tonks, A., Expression of CD200 on AML blasts directly suppresses memory T-cell function. Leukemia 2012. 26: 2148–2151.
18. Misstear, K., Chanas, S. A., Rezaee, S. A., Colman, R., Quinn, L. L., Long, H. M., Goodyear, O. et al., Suppression of antigen-specific T cell responses by the Kaposi's sarcoma-associated herpesvirus viral OX2 protein and its cellular orthologue, CD200. J. Virol. 2012. 86: 6246–6257.
19. Foster-Cuevas, M., Wright, G. J., Puklavec, M. J., Brown, M. H. and Barclay, A. N., Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor. J. Virol. 2004. 78: 7667–7676.
20. Rezaee, S. A., Gracie, J. A., McInnes, I. B. and Blackbourn, D. J., Inhibition of neutrophil function by the Kaposi's sarcoma-associated herpesvirus vOX2 protein. AIDS 2005. 19: 1907–1910.
21. Foster-Cuevas, M., Westerholt, T., Ahmed, M., Brown, M. H., Barclay, A. N. and Voigt, S., Cytomegalovirus e127 protein interacts with the inhibitory CD200 receptor. J. Virol. 2011. 85: 6055–6059.
22. Cameron, C. M., Barrett, J. W., Liu, L., Lucas, A. R. and McFadden, G., Myxoma virus M141R expresses a viral CD200 (vOX-2) that is responsible for down-regulation of macrophage and T-cell activation in vivo. J. Virol. 2005. 79: 6052–6067.
23. Akkaya, M., Kwong, L. S., Akkaya, E., Hatherley, D. and Barclay, A. N., Rabbit CD200R binds host CD200 but not CD200-like proteins from poxviruses. Virology 2016. 488: 1–8.
24. Estep, R. D., Rawlings, S. D., Li, H., Manoharan, M., Blaine, E. T., O'Connor, M. A., Messaoudi, I. et al., The rhesus rhadinovirus CD200 homologue affects immune responses and viral loads during in vivo infection. J. Virol. 2014. 88: 10635–10654.
25. Barclay, A. N. and Van den Berg, T. K., The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target. Annu. Rev. Immunol. 2014. 32: 25–50.
26. Murata, Y., Kotani, T., Ohnishi, H. and Matozaki, T., The CD47-SIRPα signalling system: its physiological roles and therapeutic application. J. Biochem. 2014. 155: 335–344.
27. Babkin, I. V. and Babkina, I. N., Molecular dating in the evolution of vertebrate poxviruses. Intervirology 2011. 54: 253–260.
28. Parkinson, J. E., Sanderson, C. M. and Smith, G. L., The vaccinia virus A38L gene product is a 33-kDa integral membrane glycoprotein. Virology 1995. 214: 177–188.
29. Cameron, C. M., Barrett, J. W., Mann, M., Lucas, A. and McFadden, G., Myxoma virus M128L is expressed as a cell surface CD47-like virulence factor that contributes to the downregulation of macrophage activation in vivo. Virology 2005. 337: 55–67.
30. Nimmerjahn, F. and Ravetch, J. V., Fcγ receptors as regulators of immune responses. Nat. Rev. Immunol. 2008. 8: 34–47.
31. Corrales-Aguilar, E., Hoffmann, K. and Hengel, H., CMV-encoded Fcγ receptors: modulators at the interface of innate and adaptive immunity. Semin. Immunopathol. 2014. 36: 627–640.
32. Lubinski, J. M., Lazear, H. M., Awasthi, S., Wang, F. and Friedman, H. M., The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo. J. Virol. 2011. 85: 3239–3249.
33. Ndjamen, B., Farley, A. H., Lee, T., Fraser, S. E. and Bjorkman, P. J., The herpes virus Fc receptor gE-gI mediates antibody bipolar bridging to clear viral antigens from the cell surface. PLoS Pathog. 2014. 10: e1003961.
34. Crnković-Mertens, I., Messerle, M., Milotić, I., Szepan, U., Kucić, N., Krmpotić, A., Jonjić, S. et al., Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control. J. Virol. 1998. 72: 1377–1382.
35. Lenac, T., Budt, M., Arapovic, J., Hasan, M., Zimmermann, A., Simic, H., Krmpotic, A. et al., The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J. Exp. Med. 2006. 203: 1843–1850.
36. Mintern, J. D., Klemm, E. J., Wagner, M., Paquet, M. E., Napier, M. D., Kim, Y. M., Koszinowski, U. H. et al., Viral interference with B7-1 costimulation: a new role for murine cytomegalovirus fc receptor-1. J. Immunol. 2006. 177: 8422–8431.
37. Bonecchi, R., Garlanda, C., Mantovani, A. and Riva, F., Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation. Cytokine 2016. 87: 37–45.
38. Alcamí, A. and Smith, G. L., A mechanism for the inhibition of fever by a virus. Proc. Natl. Acad. Sci. USA 1996. 93: 11029–11034.
39. Smith, V. P. and Alcamí, A., Expression of secreted cytokine and chemokine inhibitors by ectromelia virus. J. Virol. 2000. 74: 8460–8471.
40. Born, T. L., Morrison, L. A., Esteban, D. J., VandenBos, T., Thebeau, L. G., Chen, N., Spriggs, M. K. et al., A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response. J. Immunol. 2000. 164: 3246–3254.
41. Reading, P. C. and Smith, G. L., Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity. J. Virol. 2003. 77: 9960–9968.
42. Xiang, Y. and Moss, B., Molluscum contagiosum virus interleukin-18 (IL-18) binding protein is secreted as a full-length form that binds cell surface glycosaminoglycans through the C-terminal tail and a furin-cleaved form with only the IL-18 binding domain. J. Virol. 2003. 77: 2623–2630.
43. Greenwald, R. J., Freeman, G. J. and Sharpe, A. H., The B7 family revisited. Annu. Rev. Immunol. 2005. 23: 515–548.
44. Brzostek, J., Gascoigne, N. R. and Rybakin, V., Cell type-specific regulation of immunological synapse dynamics by B7 ligand recognition. Front. Immunol. 2016. 7: 24.
45. Strockbine, L. D., Cohen, J. I., Farrah, T., Lyman, S. D., Wagener, F., DuBose, R. F., Armitage, R. J. et al., The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J. Virol. 1998. 72: 4015–4021.
46. Tarbouriech, N., Ruggiero, F., de Turenne-Tessier, M., Ooka, T. and Burmeister, W. P., Structure of the Epstein-Barr virus oncogene BARF1. J. Mol. Biol. 2006. 359: 667–678.
47. Shim, A. H., Chang, R. A., Chen, X., Longnecker, R. and He, X., Multipronged attenuation of macrophage-colony stimulating factor signaling by Epstein-Barr virus BARF1. Proc. Natl. Acad. Sci. USA 2012. 109: 12962–12967.
48. Elegheert, J., Bracke, N., Pouliot, P., Gutsche, I., Shkumatov, A. V., Tarbouriech, N., Verstraete, K. et al., Allosteric competitive inactivation of hematopoietic CSF-1 signaling by the viral decoy receptor BARF1. Nat. Struct. Mol. Biol. 2012. 19: 938–947.
49. Hoebe, E. K., Le Large, T. Y., Tarbouriech, N., Oosterhoff, D., De Gruijl, T. D., Middeldorp, J. M. and Greijer, A. E., Epstein-Barr virus-encoded BARF1 protein is a decoy receptor for macrophage colony stimulating factor and interferes with macrophage differentiation and activation. Viral Immunol. 2012. 25: 461–470.
50. Ohashi, M., Fogg, M. H., Orlova, N., Quink, C. and Wang, F., An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection. PLoS Pathog. 2012. 8: e1003095.
51. Hoebe, E. K., Le Large, T. Y., Greijer, A. E. and Middeldorp, J. M., BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator. Rev. Med. Virol. 2013. 23: 367–383.
52. Kuespert, K., Pils, S. and Hauck, C. R., CEACAMs: their role in physiology and pathophysiology. Curr. Opin. Cell Biol. 2006. 18: 565–571.
53. Gray-Owen, S. D. and Blumberg, R. S., CEACAM1: contact-dependent control of immunity. Nat. Rev. Immunol. 2006. 6: 433–446.
54. Shikhagaie, M., Mercé-Maldonado, E., Isern, E., Muntasell, A., Albà, M. M., López-Botet, M., Hengel, H. et al., The human cytomegalovirus-specific UL1 gene encodes a late-phase glycoprotein incorporated in the virion envelope. J. Virol. 2012. 86: 4091–4101.
55. Baker, K. S. and Murcia, P. R., Poxviruses in bats … so what? Viruses 2014. 6: 1564–1577.
56. Engel, P., Eck, M. J. and Terhorst, C., The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease. Nat. Rev. Immunol. 2003. 3: 813–821.
57. Cannons, J. L., Tangye, S. G. and Schwartzberg, P. L., SLAM family receptors and SAP adaptors in immunity. Annu. Rev. Immunol. 2011. 29: 665–705.
58. Calpe, S., Wang, N., Romero, X., Berger, S. B., Lanyi, A., Engel, P. and Terhorst, C., The SLAM and SAP gene families control innate and adaptive immune responses. Adv. Immunol. 2008. 97: 177–250.
59. Veillette, A., Dong, Z., Pérez-Quintero, L. A., Zhong, M. C. and Cruz-Munoz, M. E., Importance and mechanism of ‘switch’ function of SAP family adapters. Immunol. Rev. 2009. 232: 229–239.
60. Engel, P., Pérez-Carmona, N., Albà, M. M., Robertson, K., Ghazal, P. and Angulo, A., Human cytomegalovirus UL7, a homologue of the SLAM-family receptor CD229, impairs cytokine production. Immunol. Cell Biol. 2011. 89: 753–766.
61. Pérez-Carmona, N., Farré, D., Martínez-Vicente, P., Terhorst, C., Engel, P. and Angulo, A., Signaling lymphocytic activation molecule family receptor homologs in New World monkey cytomegaloviruses. J. Virol. 2015. 89: 11323–11336.
62. Bugert, J. J., Melquiot, N. V. and Darai, G., Mapping of mRNA transcripts in the genome of molluscum contagiosum virus: transcriptional analysis of the viral slam gene family. Virus Genes 2000. 21: 189–192.
63. Martinez-Martin, N., Ramani, S. R., Hackney, J. A., Tom, I., Wranik, B. J., Chan, M., Wu, J. et al., The extracellular interactome of the human adenovirus family reveals diverse strategies for immunomodulation. Nat. Commun. 2016. 7: 11473.
64. Jayawardane, G., Russell, G. C., Thomson, J., Deane, D., Cox, H., Gatherer, D., Ackermann, M. et al., A captured viral interleukin 10 gene with cellular exon structure. J. Gen. Virol. 2008. 89: 2447–2455.
65. Shackelton, L. A. and Holmes, E. C., The evolution of large DNA viruses: combining genomic information of viruses and their hosts. Trends Microbiol. 2004. 12: 458–465.
66. Farré, D., Engel, P. and Angulo, A., Novel role of 3'UTR-embedded Alu elements as facilitators of processed pseudogene genesis and host gene capture by viral genomes. PLoS One 2016. 11: e0169196.
67. Zhao, G., Droit, L., Tesh, R. B., Popov, V. L., Little, N. S., Upton, C., Virgin, H. W. et al., The genome of Yoka poxvirus. J. Virol. 2011. 85: 10230–10238.
68. Voigt, S., Sandford, G. R., Hayward, G. S. and Burns, W. H., The English strain of rat cytomegalovirus (CMV) contains a novel captured CD200 (vOX2) gene and a spliced CC chemokine upstream from the major immediate-early region: further evidence for a separate evolutionary lineage from that of rat CMV Maastricht. J. Gen. Virol. 2005. 86: 263–274.
69. Spriggs, M. K., Hruby, D. E., Maliszewski, C. R., Pickup, D. J., Sims, J. E., Buller, R. M. and VanSlyke, J., Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 1992. 71: 145–152.
70. Alcamí, A. and Smith, G. L., A soluble receptor for interleukin-1β encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 1992. 71: 153–167.
71. Lucas, A. and McFadden, G., Secreted immunomodulatory viral proteins as novel biotherapeutics. J. Immunol. 2004. 173: 4765–4774.
72. Tardif, J. C., L'Allier, P. L., Grégoire, J., Ibrahim, R., McFadden, G., Kostuk, W., Knudtson, M. et al., A randomized controlled, phase 2 trial of the viral serpin Serp-1 in patients with acute coronary syndromes undergoing percutaneous coronary intervention. Circ. Cardiovasc. Interv. 2010. 3: 543–548.
73. Long, S. Y., Latimer, E. M. and Hayward, G. S., Review of elephant endotheliotropic herpesviruses and acute hemorrhagic disease. ILAR J. 2016. 56: 283–296.
74. Mousavinezhad-Moghaddam, M., Amin, A. A., Rafatpanah, H. and Rezaee, S. A., A new insight into viral proteins as immunomodulatory therapeutic agents: KSHV vOX2 a homolog of human CD200 as a potent anti-inflammatory protein. Iran. J. Basic Med. Sci. 2016. 19: 2–13.
75. Langlais, C. L., Jones, J. M., Estep, R. D. and Wong, S. W., Rhesus rhadinovirus R15 encodes a functional homologue of human CD200. J. Virol. 2006. 80: 3098–3103.
76. Host, K. M. and Damania, B., Discovery of a novel bat gammaherpesvirus. mSphere 2016. 1: e00016–16.
77. Shabman, R. S., Shrivastava, S., Tsibane, T., Attie, O., Jayaprakash, A., Mire, C. E., Dilley, K. E. et al., Isolation and characterization of a novel gammaherpesvirus from a microbat cell line. mSphere 2016. 1: e00070–15.
78. Wilkie, G. S., Kerr, K., Stewart, J. P., Studdert, M. J. and Davison, A. J., Genome sequences of equid herpesviruses 2 and 5. Genome Announc. 2015. 3: e00119–15.
79. Zeng, X., Chi, X., Li, W., Hao, W., Li, M., Huang, X., Huang, Y. et al., Complete genome sequence analysis of goatpox virus isolated from China shows high variation. Vet. Microbiol. 2014. 173: 38–49.
80. Afonso, C. L., Delhon, G., Tulman, E. R., Lu, Z., Zsak, A., Becerra, V. M., Zsak, L. et al., Genome of deerpox virus. J. Virol. 2005. 79: 966–977.
81. Zhang, L., Stanford, M., Liu, J., Barrett, C., Jiang, L., Barclay, A. N. and McFadden, G., Inhibition of macrophage activation by the myxoma virus M141 protein (vCD200). J. Virol. 2009. 83: 9602–9607.
82. Nazarian, S. H., Barrett, J. W., Frace, A. M., Olsen-Rasmussen, M., Khristova, M., Shaban, M., Neering, S. et al., Comparative genetic analysis of genomic DNA sequences of two human isolates of Tanapox virus. Virus Res. 2007. 129: 11–25.
83. Lee, H. J., Essani, K. and Smith, G. L., The genome sequence of Yaba-like disease virus, a yatapoxvirus. Virology 2001. 281: 170–192.
84. Brunetti, C. R., Amano, H., Ueda, Y., Qin, J., Miyamura, T., Suzuki, T., Li, X. et al., Complete genomic sequence and comparative analysis of the tumorigenic poxvirus Yaba monkey tumor virus. J. Virol. 2003. 77: 13335–13347.
85. Sanderson, C. M., Parkinson, J. E., Hollinshead, M. and Smith, G. L., Overexpression of the vaccinia virus A38L integral membrane protein promotes Ca2+ influx into infected cells. J. Virol. 1996. 70: 905–914.
86. Mavian, C., López-Bueno, A., Bryant, N. A., Seeger, K., Quail, M. A., Harris, D., Barrell, B. and Alcamí, A., The genome sequence of ectromelia virus Naval and Cornell isolates from outbreaks in North America. Virology 2014. 462–463: 218–226.
87. Li, G., Chen, N., Roper, R. L., Feng, Z., Hunter, A., Danila, M., Lefkowitz, E. J. et al., Complete coding sequences of the rabbitpox virus genome. J. Gen. Virol. 2005. 86: 2969–2977.
88. Afonso, C. L., Tulman, E. R., Lu, Z., Zsak, L., Sandybaev, N. T., Kerembekova, U. Z., Zaitsev, V. L. et al., The genome of camelpox virus. Virology 2002. 295: 1–9.
89. Fleischauer, C., Upton, C., Victoria, J., Jones, G. J. and Roper, R. L., Genome sequence and comparative virulence of raccoonpox virus: the first North American poxvirus sequence. J. Gen. Virol. 2015. 96: 2806–2821.
90. Smithson, C., Tang, N., Sammons, S., Frace, M., Batra, D., Li, Y., Emerson, G. L. et al., The genomes of three North American orthopoxviruses. Virus Genes 2017. 53: 21–34.
91. Tulman, E. R., Delhon, G., Afonso, C. L., Lu, Z., Zsak, L., Sandybaev, N. T., Kerembekova, U. Z. et al., Genome of horsepox virus. J. Virol. 2006. 80: 9244–9258.
92. Willer, D. O., McFadden, G. and Evans, D. H., The complete genome sequence of shope (rabbit) fibroma virus. Virology 1999. 264: 319–343.
93. Afonso, C. L., Tulman, E. R., Lu, Z., Zsak, L., Osorio, F. A., Balinsky, C., Kutish, G. F. et al., The genome of swinepox virus. J. Virol. 2002. 76: 783–790.
94. Darby, A. C., McInnes, C. J., Kjær, K. H., Wood, A. R., Hughes, M., Martensen, P. M., Radford, A. D. et al., Novel host-related virulence factors are encoded by squirrelpox virus, the main causative agent of epidemic disease in red squirrels in the UK. PLoS One 2014. 9: e96439.
95. Afonso, P. P., Silva, P. M., Schnellrath, L. C., Jesus, D. M., Hu, J., Yang, Y., Renne, R. et al., Biological characterization and next-generation genome sequencing of the unclassified Cotia virus SPAn232 (Poxviridae). J. Virol. 2012. 86: 5039–5054.
96. Atalay, R., Zimmermann, A., Wagner, M., Borst, E., Benz, C., Messerle, M. and Hengel, H., Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcγ receptor homologs. J. Virol. 2002. 76: 8596–8608.
97. Corrales-Aguilar, E., Trilling, M., Hunold, K., Fiedler, M., Le, V. T., Reinhard, H., Ehrhardt, K. et al., Human cytomegalovirus Fcγ binding proteins gp34 and gp68 antagonize Fcγ receptors I, II and III. PLoS Pathog. 2014. 10: e1004131.
98. Ndjamen, B., Joshi, D. S., Fraser, S. E. and Bjorkman, P. J., Characterization of antibody bipolar bridging mediated by the human cytomegalovirus Fc receptor gp68. J. Virol. 2016. 90: 3262–3267.
99. Cortese, M., Calò, S., D'Aurizio, R., Lilja, A., Pacchiani, N. and Merola, M., Recombinant human cytomegalovirus (HCMV) RL13 binds human immunoglobulin G Fc. PLoS One 2012. 7: e50166.
100. Geyer, H., Ettinger, J., Möller, L., Schmolz, E., Nitsche, A., Brune, W., Heaggans, S. et al., Rat cytomegalovirus (RCMV) English isolate and a newly identified Berlin isolate share similarities with but are separate as an anciently diverged clade from mouse CMV and the Maastricht isolate of RCMV. J. Gen. Virol. 2015. 96: 1873–1882.
101. Cousins, E. and Nicholas, J., Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication. Recent Results Cancer Res. 2014. 193: 227–268.
102. Zhang, Z., Chen, W., Sanders, M. K., Brulois, K. F., Dittmer, D. P. and Damania, B., The K1 protein of Kaposi's sarcoma-associated herpesvirus augments viral lytic replication. J. Virol. 2016. 90: 7657–7666.
103. Damania, B., Li, M., Choi, J. K., Alexander, L., Jung, J. U. and Desrosiers, R. C., Identification of the R1 oncogene and its protein product from the rhadinovirus of rhesus monkeys. J. Virol. 1999. 73: 5123–5131.
104. Shchelkunov, S. N., Totmenin, A. V., Babkin, I. V., Safronov, P. F., Ryazankina, O. I., Petrov, N. A., Gutorov, V. V. et al., Human monkeypox and smallpox viruses: genomic comparison. FEBS Lett. 2001. 509: 66–70.
105. Smith, V. P., Bryant, N. A. and Alcamí, A., Ectromelia, vaccinia and cowpox viruses encode secreted interleukin-18-binding proteins. J. Gen. Virol. 2000. 81: 1223–1230.
106. Meng, X., Leman, M. and Xiang, Y., Variola virus IL-18 binding protein interacts with three human IL-18 residues that are part of a binding site for human IL-18 receptor alpha subunit. Virology 2007. 358: 211–220.
107. Krumm, B., Meng, X., Wang, Z., Xiang, Y. and Deng, J., A unique bivalent binding and inhibition mechanism by the yatapoxvirus interleukin 18 binding protein. PLoS Pathog. 2012. 8: e1002876.
108. Nazarian, S. H., Rahman, M. M., Werden, S. J., Villeneuve, D., Meng, X., Brunetti, C., Valeriano, C. et al., Yaba monkey tumor virus encodes a functional inhibitor of interleukin-18. J. Virol. 2008. 82: 522–528.
109. Xiang, Y. and Moss, B., IL-18 binding and inhibition of interferon γ induction by human poxvirus-encoded proteins. Proc. Natl. Acad. Sci. USA 1999. 96: 11537–11542.
110. Tulman, E. R., Afonso, C. L., Lu, Z., Zsak, L., Kutish, G. F. and Rock, D. L., The genome of canarypox virus. J. Virol. 2004. 78: 353–366.
111. Afonso, C. L., Tulman, E. R., Lu, Z., Zsak, L., Kutish, G. F. and Rock, D. L., The genome of fowlpox virus. J. Virol. 2000. 74: 3815–3831.
112. Bányai, K., Palya, V., Dénes, B., Glávits, R., Ivanics, É., Horváth, B., Farkas, S. L. et al., Unique genomic organization of a novel Avipoxvirus detected in turkey (Meleagris gallopavo). Infect. Genet. Evol. 2015. 35: 221–229.
113. Offerman, K., Carulei, O., van der Walt, A. P., Douglass, N. and Williamson, A. L., The complete genome sequences of poxviruses isolated from a penguin and a pigeon in South Africa and comparison to other sequenced avipoxviruses. BMC Genomics 2014. 15: 463.
114. Ackermann, M., Koriabine, M., Hartmann-Fritsch, F., de Jong, P. J., Lewis, T. D., Schetle, N., Work, T. M. et al., The genome of Chelonid herpesvirus 5 harbors atypical genes. PLoS One 2012. 7: e46623.